SCHEMBL14907727

SCHEMBL14907727

C=CCn1c(N)c(C(=O)OC)c2nc3ccccc3nc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRK6 P43250 3/20 1.00
KDM4E B2RXH2 11/20 0.81
ALDH1A1 P00352 10/20 0.81
GAA P10253 10/20 0.81
GLA P06280 9/20 0.81
HPGD P15428 7/20 0.81
MAPT P10636 5/20 0.81
HIF1A Q16665 2/20 0.81
THRB P10828 1/20 0.81
CASP1 P29466 9/20 0.76
CASP7 P55210 9/20 0.76
HSD17B10 Q99714 9/20 0.76
KPNA2 P52292 1/20 0.76
LMNA P02545 3/20 0.73
MEN1 O00255 4/20 0.69
KMT2A Q03164 4/20 0.69
NPSR1 Q6W5P4 3/20 0.69
SMN1; SMN2 Q16637 1/20 0.69
SAE1 Q9UBE0 1/20 0.69
UBA2 Q9UBT2 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16171057 0.87 GRK6 (0.77) GRK6KDM4EALDH1A1GAAGLA
SCHEMBL14907744 0.80 GRK6 (1.00) GRK6KDM4EALDH1A1GAAGLA
SCHEMBL14907745 0.79 GRK6 (1.00) GRK6KDM4EALDH1A1GAAGLA
SCHEMBL8168686 0.71 CASP1 (0.72) GRK6KDM4EALDH1A1GAAGLA
SCHEMBL20485724 0.70 FYN (1.00) KDM4EALDH1A1GAAGLAHPGD
SCHEMBL16171058 0.69 GRK6 (0.77) GRK6KDM4EALDH1A1GAAGLA
SCHEMBL22954308 0.69 FYN (0.64) GRK6KDM4EALDH1A1GAAGLA
SCHEMBL16171183 0.68 GRK6 (0.78) GRK6KDM4EALDH1A1GAAGLA
SCHEMBL5524666 0.68 TSHR (0.65) GRK6KDM4EALDH1A1GAAGLA
SCHEMBL22954310 0.66 HSD17B10 (0.49) GRK6KDM4EALDH1A1GAAGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10252984-B2 Inhibiting G protein coupled receptor 6 kinase polypeptides MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2019-04-09 US disclosed
US-20140309185-A1 Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 2014-10-16 US disclosed
US-20140309185-A1 Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 2014-10-16 US disclosed
WO-2013063458-A2 INHIBITING G PROTEIN COUPLED RECEPTOR 6 KINASE POLYPEPTIDES MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2013-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140309185-A1 Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides GRK6, GRK2, GRK3 GRK6 1/4885KDM4E 4504/4885ALDH1A1 4731/4885
US-10252984-B2 Inhibiting G protein coupled receptor 6 kinase polypeptides GRK6, GRK2, GRK3 GRK6 1/4885KDM4E 4504/4885ALDH1A1 4731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.